This program emphasizes on the importance of hyperphosphatemia management in CKD. It describes the dietary and pharmacological strategies that can be put in place to control serum phosphate and highlights the benefits of a multidisciplinary approach to address this condition.
Learning Objectives
Upon completion of this program, participants should be able to:
- Identify the mechanisms by which patients with CKD develop hyperphosphatemia
- Describe the impact of uncontrolled hyperphosphatemia on morbidity and mortality in the CKD population
- Explain the major components of the management of hyperphosphatemia
- Counsel patients on how to reduce dietary intake of phosphate
- Describe the key characteristics of phosphate-binding agents
This program has received an educational grant or in-kind resources from Otsuka Canada Inc
